Business Wire

Groundbreaking ABS Study Explores Potential of Commercial Nuclear Propulsion

Share

The transformational impact of nuclear propulsion on the design, operation and emissions of a 14k TEU container vessel and a 157k DWT Suezmax tanker have been modeled by ABS and Herbert Engineering Corp. (HEC) in a groundbreaking study.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230726740650/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

A concept design developed as part of the study. (Photo: Business Wire)

ABS commissioned HEC to carry out the study to explore the potential of advanced modern reactor technology for commercial marine propulsion. The study is designed to help industry better understand the feasibility and safety implications of nuclear propulsion and to support future development projects.

The study, which involved input from leading nuclear reactor developers, modeled the impact of two, lead-cooled, 30MW fast reactors on the container carrier, finding it would likely increase cargo capacity and operational speed, while eliminating the need for refueling during its entire 25-year lifespan. On the Suezmax vessel, the study found the addition of four, 5MW, heat-pipe microreactors, while decreasing cargo capacity, would raise operational speeds and only require refueling once during its 25-year life. Both concept vessels would emit zero CO2.

“Our findings from this latest cutting-edge research underscore why the industry cannot afford to ignore the vast potential offered by nuclear propulsion both in terms of emissions reduction and operational efficiency. A net-zero world is more easily realized through nuclear propulsion, and we are putting in place the foundations for that future today. Turning this into a practical reality will require significant public sector support and ABS is well placed to bring governments and industry together,” said Christopher J. Wiernicki, ABS Chairman and CEO. “Advanced or small modular reactors address many of the issues traditionally associated with nuclear for commercial maritime use, with enhanced safety and efficiency, reduced cost and waste and proliferation prevention. Nevertheless, many questions need to be answered and it is critical that industry evaluate these technologies with a laser focus on safety.”

“HEC is pleased to be able to support ABS and explore the practical application of nuclear power on board. This study is helping us to understand in detail both the potential of modern reactor technology and how this will affect the design and operation of future vessels,” said Robert Tagg, Senior Principal Naval Architect at HEC.

ABS is playing a pioneering role in supporting the development of nuclear propulsion for commercial vessels. The U.S. Department of Energy (DOE) has awarded ABS a contract to research barriers to the adoption of advanced nuclear propulsion on commercial vessels. The DOE has also contracted ABS to support research into thermal-electric integration of a nuclear propulsion system on a commercial vessel being carried out by the University of Texas.

About ABS
ABS, a leading global provider of classification and technical advisory services to the marine and offshore industries, is committed to setting standards for safety and excellence in design and construction. Focused on safe and practical application of advanced technologies and digital solutions, ABS works with industry and clients to develop accurate and cost-effective compliance, optimized performance and operational efficiency for marine and offshore assets.

About HEC
HEC provides marine consulting, ship design, and software development services to shipowners, operators, shipyards, and government agencies.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information
ABS Media Relations: jmire@eagle.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 11:53:00 EET | Press release

NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a

Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 11:00:00 EET | Press release

Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeking future-ready solutions. At the core of this strategy is Regnology Risk Hub (RRiskHub), an integrated solution designed to deliver a single

Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 11:00:00 EET | Press release

Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 10:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap

DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 09:30:00 EET | Press release

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye